Comprehensive Analysis Identifies the PPAR-Targeted Genes Associated with Ovarian Cancer Prognosis and Tumor Microenvironment

Figure 6

Immunotherapy and drug sensitivity analysis. (a) Correlation between the risk score and TIDE score. (b) The level of risk score in immunotherapy responders and non-responders. (c) The level of dysfunction, exclusion, MDSC, CAF, and TAM M2 in high- and low-risk patients. (d–s) Drug sensitivity analysis.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)

(p)

(q)

(r)

(s)